Randal A. Byrn

5.4k citations

49 papers · 4.0k indexed · 1 hit paper · h-index 27

Co-authors: Jerome E. Groopman David Baltimore Timothy J. Gregory Daniel J. Capon Scot A. Marsters Douglas H. Smith Steven M. Chamow JE Groopman
Topics: HIV Research and Treatment (33 papers)HIV/AIDS drug development and treatment (19 papers)Immune Cell Function and Interaction (13 papers)
Cited by: Virology Infectious Diseases Immunology
Journals: Nature Science Proceedings of the National Academy of Sciences
Partner nations: United States Sweden Japan

In The Last Decade

Randal A. Byrn

49 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Designing CD4 immunoadhesins for AIDS therapy

1989 508 citations Daniel J. Capon, Steven M. Chamow et al. Nature profile →

Peers

Countries citing papers authored by Randal A. Byrn

Since Specialization

Citations

This map shows the geographic impact of Randal A. Byrn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randal A. Byrn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randal A. Byrn more than expected).

Fields of papers citing papers by Randal A. Byrn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Randal A. Byrn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randal A. Byrn. The network helps show where Randal A. Byrn may publish in the future.

Co-authorship network of co-authors of Randal A. Byrn

This figure shows the co-authorship network connecting the top 25 collaborators of Randal A. Byrn. A scholar is included among the top collaborators of Randal A. Byrn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Randal A. Byrn. Randal A. Byrn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preclinical Activity of VX-787, a First-in-Class, Orally Bioavailable Inhibitor of the Influenza Virus Polymerase PB2 Subunit 2014 ·Antimicrobial Agents and Chemotherapy ·Randal A. Byrn,Steven J.M. Jones,(unknown),(unknown),Michael P. Clark,Marc Jacobs,Ann D. Kwong,Mark W. Ledeboer,Joshua R. Leeman,(unknown),Mark A. Murcko,Azin Nezami,Emanuele Perola,René Rijnbrand,Kumkum Saxena,Alice Tsai,Yi Zhou,Paul S. Charifson	149
2	Natural Prevalence of Hepatitis C Virus Variants with Decreased Sensitivity to NS3·4A Protease Inhibitors in Treatment‐Naive Subjects 2008 ·The Journal of Infectious Diseases ·Doug J. Bartels,Yi Zhou,Eileen Z. Zhang,(unknown),Randal A. Byrn,Thomas Pfeiffer,Ann M. Tigges,Bambang S. Adiwijaya,Chao Lin,Ann D. Kwong,Tara L. Kieffer	162
3	Synergistic inhibition of HIV-1 by an antisense oligonucleotide and nucleoside analog reverse transcriptase inhibitors 1998 ·Antiviral Research ·Gareth J. Veal,Sudhir Agrawal,Randal A. Byrn	8
4	Analysis of human immunodeficiency virus in semen: indications of a genetically distinct virus reservoir 1998 ·Journal of Reproductive Immunology ·Randal A. Byrn,Ann A. Kiessling	43
5	The Multiple Inhibitory Mechanisms of GEM 91®, a gag Antisense Phosphorothioate Oligonucleotide, for Human Immunodeficiency Virus Type 1 1997 ·AIDS Research and Human Retroviruses ·Koushi Yamaguchi,Béla Papp,(unknown),Afsar Ali,Sudhir Agrawal,Randal A. Byrn	36
6	A Humanized, Bispecific Immunoadhesin-Antibody that Retargets CD3+ Effectors to Kill HIV-1-Infected Cells 1995 ·Journal of Hematotherapy ·Steven M. Chamow,(unknown),(unknown),(unknown),Scot A. Marsters,David Peers,Randal A. Byrn,Avi Ashkenazi,Richard P. Junghans	35
7	Clinical isolates of HIV-1 contain few pre-existing proteinase inhibitor resistance-conferring mutations 1995 ·Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology ·Koushi Yamaguchi,Randal A. Byrn	15
8	Chimeric zeta-receptors direct human natural killer (NK) effector function to permit killing of NK-resistant tumor cells and HIV-infected T lymphocytes 1995 ·The Journal of Immunology ·(unknown),(unknown),Randal A. Byrn,Michelle Roberts	103
9	Design, biochemical, biophysical and biological properties of cooperative antisense oligonucleotides 1995 ·Nucleic Acids Research ·Ekambar R. Kandimalla,(unknown),Christopher S. Lathan,Randal A. Byrn,Sudhir Agrawal	20
10	Stimulation of Human Immunodeficiency Virus Type 1 Expression by Ceramide 1994 ·AIDS Research and Human Retroviruses ·Béla Papp,(unknown),Jerome E. Groopman,Randal A. Byrn	14
11	The regulation of HIV by retinoic acid correlates with cellular expression of the retinoic acid receptors 1994 ·AIDS ·Koushi Yamaguchi,Jerome E. Groopman,Randal A. Byrn	32
12	A Modified Nonradioactive Method for Northern Blot Analysis 1994 ·Analytical Biochemistry ·Koushi Yamaguchi,Zhengwen Zhang,Randal A. Byrn	5
13	Comparison of the immune response to recombinant gp120 in humans and chimpanzees 1994 ·AIDS ·Phillip W. Berman,Donna J. Eastman,(unknown),Gerald Nakamura,Timothy J. Gregory,David H. Schwartz,Geoffrey J. Gorse,Robert B. Belshe,M L Clements,Randal A. Byrn	25
14	Neutralization of HIV-1 by F105, a human monoclonal antibody to the CD4 binding site of gp120. 1993 ·PubMed ·(unknown),(unknown),(unknown),(unknown),Randal A. Byrn	122
15	Monoclonal Antibodies to the Extracellular Domain of HIV-1IIIB gp160 that Neutralize Infectivity, Block Binding to CD4, and React with Diverse Isolates 1992 ·AIDS Research and Human Retroviruses ·Gerald Nakamura,Randal A. Byrn,(unknown),James P. Porter,Maurine R. Hobbs,L Riddle,Donna J. Eastman,Donald Dowbenko,Tim Gregory,B M Fendly,Phillip W. Berman	26
16	An IgG human monoclonal antibody that reacts with HIV-1/GP120, inhibits virus binding to cells, and neutralizes infection 1991 ·The Journal of Immunology ·Marshall R. Posner,Teru Hideshima,Timothy Lewis Cannon,M Mukherjee,Karl Mayer,Randal A. Byrn	232
17	Inhibition of Serum-Enhanced HIV-1 Infection of U937 Monocytoid Cells by Recombinant Soluble CD4 and Anti-CD4 Monoclonal Antibody 1990 ·AIDS Research and Human Retroviruses ·Michael Zeira,Randal A. Byrn,(unknown)	24
18	Biological properties of a CD4 immunoadhesin 1990 ·Nature ·Randal A. Byrn,Joyce Mordenti,Catherine Lucas,Douglas H. Smith,Scot A. Marsters,Jennifer Johnson,Paul A. Cossum,Steven M. Chamow,Florian Μ. Wurm,Timothy J. Gregory,Jerome E. Groopman,Daniel J. Capon	140
19	Production of tumor necrosis factor alpha and interleukin 1 beta by monocytic cells infected with human immunodeficiency virus. 1989 ·Journal of Clinical Investigation ·Jean‐Michel Molina,David T. Scadden,Randal A. Byrn,Charles A. Dinarello,J E Groopman	147
20	Designing CD4 immunoadhesins for AIDS therapybreakdown → 1989 ·Nature ·Daniel J. Capon,Steven M. Chamow,Joyce Mordenti,Scot A. Marsters,Timothy J. Gregory,Hiroaki Mitsuya,Randal A. Byrn,Catherine Lucas,Florian Μ. Wurm,Jerome E. Groopman,Samuel Broder,Douglas H. Smith	508

About Randal A. Byrn

Randal A. Byrn is a scholar working on Virology, Infectious Diseases and Immunology, having authored 49 papers that have together received 4.0k indexed citations. Recurring topics across this work include HIV Research and Treatment (33 papers), HIV/AIDS drug development and treatment (19 papers) and Immune Cell Function and Interaction (13 papers). The work is most often cited by research in Virology (2.3k citations), Infectious Diseases (1.4k citations) and Immunology (1.5k citations). Randal A. Byrn has collaborated with scholars based in United States, Sweden and Japan. Frequent co-authors include Jerome E. Groopman, David Baltimore, Timothy J. Gregory, Daniel J. Capon, Scot A. Marsters, Douglas H. Smith, Steven M. Chamow, JE Groopman, Kenji Ikeuchi and R. Alan B. Ezekowitz. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact